ImageneBio Inc
57 hedge funds and large institutions have $49.1M invested in ImageneBio Inc in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 20 reducing their positions, and 18 closing their positions.
3% more capital invested
Capital invested by funds: $47.9M → $49.1M (+$1.28M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.68% less ownership
Funds ownership: 69.25% → 67.57% (-1.7%)
19% less funds holding
Funds holding: 70 → 57 (-13)
45% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 20
72% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
+$390K |
| 2 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$233K |
| 3 |
VAM
Vazirani Asset Management
New York
|
+$195K |
| 4 |
BP
BBR Partners
New York
|
+$185K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$128K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$363K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$284K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
-$223K |
| 4 |
Millennium Management
New York
|
-$177K |
| 5 |
Two Sigma Investments
New York
|
-$135K |
IMA Hedge Fund Activity: Q3 2024 in Review
57 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q3 2024, worth a combined $49.1M — up 2.7% from $47.9M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of IMA and 5 opened new positions — a net loss of 13 holders — while 20 trimmed existing stakes and 11 added.
The largest buyer was FNY Investment Advisers, opening a new position worth an estimated $390K. The largest seller was Goldman Sachs, cutting an estimated $363K.
- 57 institutional investors held ImageneBio Inc (IMA) as of Q3 2024, down from 70 in Q2 2024.
- Funds reported $49.1M of ImageneBio Inc stock for Q3 2024, up 2.7% quarter-over-quarter.
- 5 funds opened new ImageneBio Inc positions in Q3 2024 and 18 closed out, a net change of -13 holders.
- The largest ImageneBio Inc buyer in Q3 2024 was FNY Investment Advisers, an estimated $390K added.
- The largest ImageneBio Inc seller in Q3 2024 was Goldman Sachs, an estimated $363K sold.
Based on aggregated 13F filings for Q3 2024.